130 related articles for article (PubMed ID: 2363118)
21. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
23. Activation of platelets by alpha-thrombin is a receptor-mediated event. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone-thrombin, but not N alpha-tosyl-L-lysine chloromethyl ketone-thrombin, binds to the high affinity thrombin receptor.
Harmon JT; Jamieson GA
J Biol Chem; 1986 Dec; 261(34):15928-33. PubMed ID: 3023333
[TBL] [Abstract][Full Text] [Related]
24. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents.
Lages B; Weiss HJ
Thromb Haemost; 1981 Apr; 45(2):173-9. PubMed ID: 6789496
[TBL] [Abstract][Full Text] [Related]
25. Prevention of heparin-resistant thrombotic occlusion of hollow-fiber hemodialyzers by synthetic antithrombin.
Kelly AB; Hanson SR; Henderson LW; Harker LA
J Lab Clin Med; 1989 Oct; 114(4):411-8. PubMed ID: 2794754
[TBL] [Abstract][Full Text] [Related]
26. Effects of ethanol on platelet function.
Hillbom M; Kangasaho M; Löwbeer C; Kaste M; Muuronen A; Numminen H
Alcohol; 1985; 2(3):429-32. PubMed ID: 4026960
[TBL] [Abstract][Full Text] [Related]
27. Anesthetics and anticoagulants used in the preparation of rat platelet-rich-plasma alter rat platelet aggregation.
Dwyer SD; Meyers KM
Thromb Res; 1986 Apr; 42(2):139-51. PubMed ID: 3087006
[TBL] [Abstract][Full Text] [Related]
28. Changes in the blood platelets of alcoholics during alcohol withdrawal.
Fink R; Hutton RA
J Clin Pathol; 1983 Mar; 36(3):337-40. PubMed ID: 6219131
[TBL] [Abstract][Full Text] [Related]
29. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
Viisoreanu D; Gear A
Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
[TBL] [Abstract][Full Text] [Related]
30. Effects of vitamin E therapy on ethanol-induced changes in platelet aggregation, thromboxane formation, factor VIII levels and serum lipids.
Hillbom M; Muuronen A; Neiman J; Björk G; Egberg N; Kangasaho M
Eur J Clin Invest; 1987 Feb; 17(1):68-74. PubMed ID: 3106052
[TBL] [Abstract][Full Text] [Related]
31. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
Fiedel BA; Gewurz H
J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
[TBL] [Abstract][Full Text] [Related]
32. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone (PPACK): alternative anticoagulant to heparin salts for blood gas and electrolyte specimens.
Lyon ME; Fine JS; Henderson PJ; Lyon AW
Clin Chem; 1995 Jul; 41(7):1038-41. PubMed ID: 7600685
[TBL] [Abstract][Full Text] [Related]
33. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
Kobzar G; Mardla V; Samel N
Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
[TBL] [Abstract][Full Text] [Related]
34. Preservation of platelet aggregation and dense granule secretion during extended storage of blood samples in the presence of a synthetic dual inhibitor of factor Xa and thrombin.
Haubelt H; Vogt A; Hellstern P
Platelets; 2008 Nov; 19(7):496-501. PubMed ID: 18979361
[TBL] [Abstract][Full Text] [Related]
35. Increased urinary excretion of a major thromboxane metabolite in early alcohol withdrawal.
Neiman J; Nowak J; Benthin G; Numminen H; Hillbom M
Clin Physiol; 1994 Jul; 14(4):405-9. PubMed ID: 7955938
[TBL] [Abstract][Full Text] [Related]
36. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
37. Reaction of acetaldehyde with human platelets.
Spertini O; Hauert J; Bachmann F
Thromb Haemost; 1992 Jan; 67(1):126-30. PubMed ID: 1615467
[TBL] [Abstract][Full Text] [Related]
38. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
39. Does the magnetic field of a magnetic stirrer in an optical aggregometer affect concurrent platelet aggregation?
Sagdilek E; Sebik O; Celebi G
Bioelectromagnetics; 2013 Jul; 34(5):349-57. PubMed ID: 23436227
[TBL] [Abstract][Full Text] [Related]
40. Effects of anticoagulant on pH, ionized calcium concentration, and agonist-induced platelet aggregation in canine platelet-rich plasma.
Callan MB; Shofer FS; Catalfamo JL
Am J Vet Res; 2009 Apr; 70(4):472-7. PubMed ID: 19335102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
